192 related articles for article (PubMed ID: 8781139)
1. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.
Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Samnick S; Maasjosthusmann U; Lerch H; Gildehaus FJ; Wassmann H; Schober O
Eur J Nucl Med; 1996 Oct; 23(10):1345-53. PubMed ID: 8781139
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
[TBL] [Abstract][Full Text] [Related]
3. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
[TBL] [Abstract][Full Text] [Related]
5. Sequential scintigraphic strategy for the differentiation of brain tumours.
Matheja P; Rickert C; Weckesser M; Palkovic S; Löttgen J; Riemann B; Kopka K; Kuwert T; Wassmann H; Paulus W; Schober O
Eur J Nucl Med; 2000 May; 27(5):550-8. PubMed ID: 10853811
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
[TBL] [Abstract][Full Text] [Related]
7. Influence of size of regions of interest on the measurement of uptake of 123I-alpha-methyl tyrosine by brain tumours.
Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Schäfers M; Wassmann H; Schober O
Nucl Med Commun; 1996 Jul; 17(7):609-15. PubMed ID: 8843121
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.
Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O
J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732
[TBL] [Abstract][Full Text] [Related]
9. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas.
Hellwig D; Romeike BF; Ketter R; Moringlane JR; Kirsch CM; Samnick S
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):24-31. PubMed ID: 17846769
[TBL] [Abstract][Full Text] [Related]
10. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent.
Weckesser M; Griessmeier M; Schmidt D; Sonnenberg F; Ziemons K; Kemna L; Holschbach M; Langen K; Müller-Gärtner H
Eur J Nucl Med; 1998 Feb; 25(2):150-6. PubMed ID: 9473263
[TBL] [Abstract][Full Text] [Related]
11. Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity.
Kuwert T; Probst-Cousin S; Woesler B; Morgenroth C; Lerch H; Matheja P; Palkovic S; Schäfers M; Wassmann H; Gullotta F; Schober O
J Nucl Med; 1997 Oct; 38(10):1551-5. PubMed ID: 9379191
[TBL] [Abstract][Full Text] [Related]
12. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
[TBL] [Abstract][Full Text] [Related]
13. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.
Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW
J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193
[TBL] [Abstract][Full Text] [Related]
14. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
[TBL] [Abstract][Full Text] [Related]
15. [The role of L-3-I-123-iodine-alpha-methyltyrosine SPECT in cerebral gliomas].
Weckesser M; Schmidt D; Matheja P; Coenen HH; Langen KJ
Nuklearmedizin; 2000 Dec; 39(8):233-40. PubMed ID: 11189900
[TBL] [Abstract][Full Text] [Related]
16. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.
Grosu AL; Feldmann H; Dick S; Dzewas B; Nieder C; Gumprecht H; Frank A; Schwaiger M; Molls M; Weber WA
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):842-54. PubMed ID: 12377338
[TBL] [Abstract][Full Text] [Related]
17. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
Plotkin M; Amthauer H; Eisenacher J; Wurm R; Michel R; Wust P; Stockhammer F; Röttgen R; Gutberlet M; Ruf J; Felix R
Neuroradiology; 2005 Jan; 47(1):18-26. PubMed ID: 15630586
[TBL] [Abstract][Full Text] [Related]
18. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
[TBL] [Abstract][Full Text] [Related]
19. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas.
Grosu AL; Weber W; Feldmann HJ; Wuttke B; Bartenstein P; Gross MW; Lumenta C; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):517-26. PubMed ID: 10802381
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
